Millions of patients in the United Kingdom (UK) are being urged to check their blood pressure medication after health chiefs issued an urgent recall of a batch of Ramipril tablets.
The Medicines and Healthcare products Regulatory Agency (MHRA) said a batch of Ramipril 2.5mg capsules, made by Crescent Pharma Limited, may contain strips wrongly labelled as 10mg.
According to the MHRA, the affected batch carries code "GR155023" on the packaging.
Ramipril is one of the most commonly prescribed drugs in the UK, with around three million prescriptions issued each month.
It is used to treat high blood pressure, kidney disease, heart failure and to prevent complications after a heart attack by relaxing and widening blood vessels.
READ ALSO: Trump Administration Seeks $250 Bill with President’s Portrait
The regulator said patients who received the wrong dose could experience dizziness, fainting, unusual fatigue or changes in kidney function. The risks are greater for "vulnerable patients," it added.
Those with the affected pack were asked to take the medicine leaflet and any remaining capsules to their pharmacy or GP for advice.
Patients who feel unwell after taking a higher dose were also advised to contact NHS 111.
Dr Alison Cave, MHRA Chief Safety Officer, said: "If you have batch GR155023, check that the strength on the carton matches the blisters inside.
"If your 2.5mg carton contains 10mg capsules, do not take them and contact your pharmacy. If the strips are correctly labelled as 2.5mg, continue taking your medicine as usual."
Pharmacies and healthcare providers have been told to stop supplying the batch and return all remaining stock.
It was said that side effects can also be reported via the MHRA Yellow Card scheme.
0 Comments